CCOP - North Shore University Hospital — Manhasset, New York

CCOP - North Shore University Hospital is a clinical research site located in Manhasset, New York, United States 11030.

Crixeo Clinical Trials Trust Score: 90/100 (GOOD). This profile has not yet been claimed by the site owner.

CCOP - North Shore University Hospital has participated in 167 clinical trials with 3 currently active.

Therapeutic areas: Breast Cancer, Esophageal Cancer, Unspecified Adult Solid Tumor, Protocol Specific.

Sponsors: NSABP Foundation Inc, Alliance for Clinical Trials in Oncology, Radiation Therapy Oncology Group.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Manhasset

Browse all research sites in New York · View every site in Manhasset

Sponsor Feasibility Report

Trust Score: 90/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for CCOP - North Shore University Hospital?

CCOP - North Shore University Hospital has a Crixeo Trust Score of 90/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has CCOP - North Shore University Hospital conducted?

CCOP - North Shore University Hospital has 167 clinical trials on record, with 3 currently active. Their work covers Breast Cancer, Esophageal Cancer, Unspecified Adult Solid Tumor, Protocol Specific.

Is CCOP - North Shore University Hospital accredited by Crixeo Clinical Trials?

CCOP - North Shore University Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about CCOP - North Shore University Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.